Pacira Biosciences Inc PCRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:41 PM CEST
54.62quote price arrow down-1.32 (-2.36%)
Volume
161,786
52 week range
48.23 - 80.00
Loading...
  • Open55.19
  • Day High55.28
  • Day Low54.37
  • Prev Close55.94
  • 52 Week High80.00
  • 52 Week High Date02/25/21
  • 52 Week Low48.23
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap2.428B
  • Shares Out44.45M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-8.88

KEY STATS

  • Open55.19
  • Day High55.28
  • Day Low54.37
  • Prev Close55.94
  • 52 Week High80.00
  • 52 Week High Date02/25/21
  • 52 Week Low48.23
  • 52 Week Low Date10/29/20
  • Market Cap2.428B
  • Shares Out44.45M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-8.88

RATIOS/PROFITABILITY

  • EPS (TTM)3.91
  • P/E (TTM)13.98
  • Fwd P/E (NTM)16.33
  • EBITDA (MRQ)120.158M
  • ROE (MRQ)32.38%
  • Revenue (MRQ)503.08M
  • Gross Margin (MRQ)73.78%
  • Net Margin (MRQ)34.60%
  • Debt To Equity (MRQ)69.18%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pacira Biosciences Inc

There is no recent news for this security.

Profile

MORE
Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local...
David Stack
Chairman
Charles Reinhart III
Chief Financial Officer
Address
5 Sylvan Way Ste 300
Parsippany, NJ
07054-3813
United States

Top Peers

SYMBOLLASTCHG%CHG
CORT
Corcept Therapeutics Inc
20.30-0.21-1.02%
IRWD
Ironwood Pharmaceuticals Inc
12.26-0.09-0.77%
AMRN
Amarin Corporation PLC
4.97-0.17-3.40%
HSKA
Heska Corp
248.13-12.73-4.88%
HRMY
Harmony Biosciences Holdings Inc
36.90+0.11+0.30%